Prevalence of Premalignant Conditions and Their Transformation Into Oral Cancers: A Clinical Study

IF 0.8 Q3 Pharmacology, Toxicology and Pharmaceutics
Batchu Pavan Kumar, Pallavi Narra, Vuyyuru Vidya Devi, Vishnu Gowtham Marella, Saudamini More, S. Mujoo, Neshaneni Satish Kumar
{"title":"Prevalence of Premalignant Conditions and Their Transformation Into Oral Cancers: A Clinical Study","authors":"Batchu Pavan Kumar, Pallavi Narra, Vuyyuru Vidya Devi, Vishnu Gowtham Marella, Saudamini More, S. Mujoo, Neshaneni Satish Kumar","doi":"10.4103/jpbs.jpbs_384_24","DOIUrl":null,"url":null,"abstract":"ABSTRACT\n \n \n \n The purpose of this study is to look at how often premalignant oral diseases are among patients who visit a tertiary care center, as well as how often these problems progress to become mouth malignancies.\n \n \n \n Between 2017 and 2022, 200 patients at a tertiary care facility who were identified with premalignant oral lesions had their medical records retrospectively examined. Information on lesion features, histological results, and demographics was gathered. Statistical analysis was used to determine the prevalence of premalignant oral lesions and the rate at which these lesions turned into oral malignancies, with a significance threshold of P < 0.05.\n \n \n \n The research population’s mean age was 55 years (SD ± 10), with a 65% male preponderance. The most prevalent premalignant lesions were leukoplakia (45%), erythroplakia (30%), and oral submucous fibrosis (25%). Remarkably, during follow-up, 40% of patients showed development of premalignant lesions into mouth malignancies. Based on statistical analysis, there were significant correlations (P < 0.05) between dysplastic alterations, age, tobacco use, and the development of oral malignancies from premalignant lesions.\n \n \n \n In conclusion, this study highlights the need of early diagnosis and focused therapies in tertiary care settings by offering important insights into the occurrence and evolution of premalignant oral lesions. The results provide important information that may be used to create screening programs and preventive measures that will lessen the incidence of oral cancer.\n","PeriodicalId":16824,"journal":{"name":"Journal of Pharmacy and Bioallied Sciences","volume":" 7","pages":""},"PeriodicalIF":0.8000,"publicationDate":"2024-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmacy and Bioallied Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jpbs.jpbs_384_24","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

ABSTRACT The purpose of this study is to look at how often premalignant oral diseases are among patients who visit a tertiary care center, as well as how often these problems progress to become mouth malignancies. Between 2017 and 2022, 200 patients at a tertiary care facility who were identified with premalignant oral lesions had their medical records retrospectively examined. Information on lesion features, histological results, and demographics was gathered. Statistical analysis was used to determine the prevalence of premalignant oral lesions and the rate at which these lesions turned into oral malignancies, with a significance threshold of P < 0.05. The research population’s mean age was 55 years (SD ± 10), with a 65% male preponderance. The most prevalent premalignant lesions were leukoplakia (45%), erythroplakia (30%), and oral submucous fibrosis (25%). Remarkably, during follow-up, 40% of patients showed development of premalignant lesions into mouth malignancies. Based on statistical analysis, there were significant correlations (P < 0.05) between dysplastic alterations, age, tobacco use, and the development of oral malignancies from premalignant lesions. In conclusion, this study highlights the need of early diagnosis and focused therapies in tertiary care settings by offering important insights into the occurrence and evolution of premalignant oral lesions. The results provide important information that may be used to create screening programs and preventive measures that will lessen the incidence of oral cancer.
癌前病变及其转化为口腔癌的发生率:临床研究
摘要 本研究的目的是了解在一家三级医疗中心就诊的患者中,口腔恶性前疾病的发生率有多高,以及这些问题发展成为口腔恶性肿瘤的频率有多高。 2017 年至 2022 年间,一家三级医疗机构对 200 名被确认患有口腔恶性前病变的患者的病历进行了回顾性检查。收集了病变特征、组织学结果和人口统计学信息。统计分析用于确定口腔恶性前病变的患病率以及这些病变转化为口腔恶性肿瘤的比率,显著性阈值为 P <0.05。 研究对象的平均年龄为 55 岁(SD ± 10),男性占 65%。最常见的癌前病变是白斑(45%)、红斑(30%)和口腔黏膜下纤维化(25%)。值得注意的是,在随访期间,40%的患者的恶性前病变发展为口腔恶性肿瘤。根据统计分析,发育不良改变、年龄、吸烟与口腔恶性肿瘤从恶性前病变发展为恶性肿瘤之间存在显著相关性(P < 0.05)。 总之,本研究通过对口腔恶性前病变的发生和演变提供重要见解,强调了在三级医疗机构进行早期诊断和重点治疗的必要性。研究结果提供的重要信息可用于制定筛查计划和预防措施,从而降低口腔癌的发病率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.50
自引率
0.00%
发文量
275
审稿时长
34 weeks
期刊介绍: Journal of Pharmacy And Bioallied Sciences is a Quarterly multidisciplinary open access biomedical journal. Journal of Pharmacy And Bioallied Sciences is an international medium of interaction between scientist, academicians and industrial personnel’s.JPBS is now offial publication of OPUBS.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信